|Shattock: Novel Antigens for Mucosal Protection
|Protein & peptide vaccines
|Study Start Date:
|Study Made Public:
Functional antibody and T cell responses in samples obtained from MUCOVAC02 human clinical trial
CAVD 268 evaluates immune responses in samples from the MUCOVAC2 Phase I clinical trial, which assessed CN54 gp140 immunization at different doses with different routes and adjuvants.
Sign in to see full information about this study and to download study data.